| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 03/24/2009 | US7507537 Cytotoxicity mediation of cells evidencing surface expression of CD44 |
| 03/24/2009 | US7507529 genetic amplification of a target nucleic acid in biological samples containing primate T-lymphotropic viruses (PTLVs), include human and simian T-lymphotropic viruses (HTLV and STLV), and detecting the strain of PTLV contained in the sample by determining nucleotide fragments that have been amplified |
| 03/24/2009 | US7507420 Peptidyl prodrugs and linkers and stabilizers useful therefor |
| 03/24/2009 | US7507419 Topically applied Clostridium botulinum toxin compositions and treatment methods |
| 03/24/2009 | US7507418 Adenovirus status as a predictor of body composition change, disease status, and treatment outcomes |
| 03/24/2009 | US7507417 Glycoproteins; antigens |
| 03/24/2009 | US7507416 adjuvant compound chosen from the acrylic or methacrylic polymers and the copolymers of maleic anhydride and an alkenyl derivative especially with polyalkenyl ethers of sugars or polyalcohols; heterologus influenza protein |
| 03/24/2009 | US7507415 West nile virus vaccine |
| 03/24/2009 | US7507414 Therapeutic polypeptide with prolonged shelf-life and increased half life for use in treatment of cell proliferative, cardiovascular, inflammatory and autoimmune disorders |
| 03/24/2009 | US7507413 Albumin fusion proteins |
| 03/24/2009 | US7507412 for drug screening; kits for collagen and/or platelet-collagen interaction; for treatment of thrombotic and cardiovascular events and disorders |
| 03/24/2009 | US7507411 Attenuated influenza NS1 variants |
| 03/24/2009 | US7507410 Monoclonal antibody DS6, tumor-associated antigen CA6, and methods of use thereof |
| 03/24/2009 | US7507408 Anti hepatitis C virus antibody and uses thereof |
| 03/24/2009 | US7507407 Immunoliposomes that optimize internationalization into target cells |
| 03/24/2009 | US7507406 administering immunoglobulins linked to proteins having amino acid replacements in the amino acid sequence, to increase the circulating half-life in vivo than a corresponding antibody-based fusion proteins without amino acid replacements; reducing tumor size and metastasis in mammals |
| 03/24/2009 | US7507405 drug/polymer and biological conjugates/, used as angiogenesis inhibitors, for diagnosis and therapy of vision disorders |
| 03/24/2009 | US7507404 PRO polypeptides; monoclonal/humanized antibodies; fusion proteins |
| 03/24/2009 | US7507403 drugs comprising an isolated protein, mixed with pharmaceutically acceptable carriers, excipients or diluents, used as an immunogenic composition for stimulating or enhancing the production of antibodies directed against the protein |
| 03/24/2009 | CA2407894C Clearance of ras-mediated neoplastic cells from mixed cellular compositions using reovirus |
| 03/24/2009 | CA2316975C Procedures for the extraction and isolation of bacterial capsular polysaccharides for use as vaccines or linked to proteins as conjugate vaccines |
| 03/24/2009 | CA2267456C Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same |
| 03/23/2009 | CA2701047A1 Antibody against anthrax toxins |
| 03/19/2009 | WO2009036407A2 Compositions and methods for regulating cellular protection |
| 03/19/2009 | WO2009036338A2 Methods for addressing ocular diseases through interference with the wnt signaling pathway |
| 03/19/2009 | WO2009036241A1 Live attenuated mycoplasma strains |
| 03/19/2009 | WO2009036209A2 Homogeneous antibody populations |
| 03/19/2009 | WO2009036157A1 Donor specific antibody libraries |
| 03/19/2009 | WO2009036081A1 Systems and methods for diagnosis and monitoring of bacteria-related conditions |
| 03/19/2009 | WO2009036063A1 Pseudotyped retroviral vectors and methods of making and using them |
| 03/19/2009 | WO2009035971A2 Compositions and methods for preventing influenza infection in canines, felines and equines |
| 03/19/2009 | WO2009035791A1 Lox and l0xl2 inhibitors and uses thereof |
| 03/19/2009 | WO2009035786A1 Humanized anti-fgf19 antagonists and methods using same |
| 03/19/2009 | WO2009035644A1 Attenuated mycoplasma gallisepticum strains |
| 03/19/2009 | WO2009035577A1 Antigen binding proteins capable of binding thymic stromal lymphopoietin |
| 03/19/2009 | WO2009035420A1 Monoclonal antibodies specific to hemagglutinin and neuraminidase from influenza virus h5-subtype or n1-subtype and uses thereof |
| 03/19/2009 | WO2009035412A1 Monoclonal antibodies specific to hemagglutinin from influenza virus h5-subtype and uses thereof |
| 03/19/2009 | WO2009035347A1 Peptide-lipid constructs and their use in diagnostic and therapeutic applications |
| 03/19/2009 | WO2009035160A1 Candidate molecule for falciparum malaria vaccine |
| 03/19/2009 | WO2009035055A1 Insulin-like growth factor-1 (igf-1) production promoter |
| 03/19/2009 | WO2009034958A1 Protein stabilizer, method for producing the same, method for using protein stabilizer, and method for stabilizing protein |
| 03/19/2009 | WO2009034575A1 Attenuated ehrlichiosis vaccine |
| 03/19/2009 | WO2009034574A2 Methods of treating tumors in immune-privileged sites |
| 03/19/2009 | WO2009034473A2 Gas57 mutant antigens and gas57 antibodies |
| 03/19/2009 | WO2009034315A2 Vaccine |
| 03/19/2009 | WO2009034182A1 Polynucleotides allowing the expression and secretion of recombinant pseudo-virus containing foreign epitopes, their production, and use |
| 03/19/2009 | WO2009033743A1 Monoclonal amyloid beta (abeta)-specific antibody and uses thereof |
| 03/19/2009 | WO2009033742A2 Streptococcus pneumoniae vaccines |
| 03/19/2009 | WO2009033726A2 Use of cart (55-102), optionally in combination with tuftsin, as a therapeutic agent |
| 03/19/2009 | WO2009033678A2 Use of a tuftsin as a therapeutic agent |
| 03/19/2009 | WO2009033309A1 HUMANIZED ANTIBODIES AGAINST THE ß-AMYLOYD PEPTIDE |
| 03/19/2009 | WO2009033285A1 Apparatus and method for dehydrating biological materials |
| 03/19/2009 | WO2009033282A1 Mitogen-activated protein kinase kinase kinase 14 (map3k14) polymorphisms as indicators of subject outcome in critically ill subjects |
| 03/19/2009 | WO2009033276A1 Malva mosaic virus and virus-like particles and uses thereof |
| 03/19/2009 | WO2009033269A1 Novel polysaccharide immunogens from alloiococcus otitidis and synthesis of a glycoconjugate vaccine thereof |
| 03/19/2009 | WO2009033268A1 Novel polysaccharide immunogens from clostridium difficile |
| 03/19/2009 | WO2009033259A1 An anti-cancer cytotoxic monoclonal antibody |
| 03/19/2009 | WO2009033233A1 Novel p2x7 epitopes |
| 03/19/2009 | WO2009033212A1 The use of estrogen and androgen binding proteins in methods and compositions for treating gynaecological cancers |
| 03/19/2009 | WO2009017679A3 Igf-1r specific antibodies useful in the detection and diagnosis of cellular proliferative disorders |
| 03/19/2009 | WO2009014708A3 Pd-1 antibodies in combination with a cytokine-secreting cell and methods of use thereof |
| 03/19/2009 | WO2009013551A3 Process for preparing viral vaccine |
| 03/19/2009 | WO2008157419A3 Immunogenic peptides of influenza virus |
| 03/19/2009 | WO2008156914A3 Synthetic replikin peptides against pathogenic infection of invertebrates in aquaculture |
| 03/19/2009 | WO2008156681A3 Adenoviral vectors for influenza virus production |
| 03/19/2009 | WO2008153926A3 Inhibitors of receptor tyrosine kinases and methods of use thereof |
| 03/19/2009 | WO2008143954A3 Single-chain fc (scfc) regions, binding polypeptides comprising same, and methods related thereto |
| 03/19/2009 | WO2008136867A3 Chlamydia pneumoniae vaccine and methods for administering such a vaccine |
| 03/19/2009 | WO2008133663A3 Codon modified immunogenic compositions and methods of use |
| 03/19/2009 | WO2008130814A3 Use of an mmp28 inhibitor for increasing myelination |
| 03/19/2009 | WO2008121487A3 Live attenuated virus vaccines for la crosse virus and other bunyaviridae |
| 03/19/2009 | WO2008118592A3 Use of an avirulent bordetella mutant as a live vaccine vector |
| 03/19/2009 | WO2008079539A3 Recombinant herpesvirus with diminished latency and methods of using same |
| 03/19/2009 | WO2008079352A3 Antibodies to cd200r |
| 03/19/2009 | WO2008020330A3 Immunogens from uropathogenic escherichia coli |
| 03/19/2009 | WO2007136763A3 Immunological composition |
| 03/19/2009 | WO2007047609A3 INHIBITION OF PLACENTA GROWTH FACTOR (PlGF) MEDICATED METASTASIS AND/OR ANGIOGENESIS |
| 03/19/2009 | WO2005062977A3 Prostate cancer specific internalizing human antibodies |
| 03/19/2009 | WO2005060667A3 Nucleic acid and amino acid sequences involved in pain |
| 03/19/2009 | US20090076245 HIV-1 Subtype Isolate Regulatory/Accessory Genes, and Modification and Derivatives Thereof |
| 03/19/2009 | US20090075886 Dendritic cell stimulatory factor |
| 03/19/2009 | US20090075884 Human il-17f and other il-17f-related proteins and methods related thereto |
| 03/19/2009 | US20090075882 Receptor-mediated uptake of an extracellular bcl-xl fusion protein inhibits apoptosis |
| 03/19/2009 | US20090075879 Novel Peptide Compositions and the Use Thereof, in Particular, in the Preparation of Active Pharmaceutical Compositions Against the Hepatitis C Virus |
| 03/19/2009 | US20090075873 Gastrin compositions and formulations, and methods of use and preparation |
| 03/19/2009 | US20090075839 Novel streptococcus pneumoniae open reading frames encoding polypeptide antigents and uses thereof |
| 03/19/2009 | US20090075384 contain alphavirus 5' and alphavirus 3' replication recognition sequences and a nucleotide sequence encoding an alphavirus structural protein; alphavirus replicon particles useful as immunostimulants |
| 03/19/2009 | US20090075368 Outer membrane protein of Ehrlichia canis and Ehrlichia chaffeensis |
| 03/19/2009 | US20090075340 Kir-Binding Agents and Methods of Use Thereof |
| 03/19/2009 | US20090075303 Allo and Auto-Reactive T-Cell Epitopes |
| 03/19/2009 | US20090075302 Compositions and methods for the diagnosis and treatment of tumor |
| 03/19/2009 | US20090075279 Compositions and methods for the diagnosis and treatment of tumor |
| 03/19/2009 | US20090075278 Compositions and methods for the diagnosis and treatment of tumor |
| 03/19/2009 | US20090074870 Alteration of cell membrane for new functions |
| 03/19/2009 | US20090074853 Vaccines with enhanced immune response and methods for their preparation |
| 03/19/2009 | US20090074851 Cpg-packaged liposomes |
| 03/19/2009 | US20090074818 Composition Comprising Parasite Eggs And Methods For Isolation And Storage Of Parasite Eggs |
| 03/19/2009 | US20090074817 Type iii secretion pathway in aeromonas salmonicida, and uses therefor |
| 03/19/2009 | US20090074816 Tissue targeted antigenic activation of the immune response to cancers |
| 03/19/2009 | US20090074815 Immunomodulator Compounds as Vaccine Enhancers |